Recombinant Human APRIL/TNFSF13 (HEK293-expressed) Protein

Carrier Free

Catalog # Availability Size / Price Qty
5860-AP-010/CF

With Carrier

Catalog # Availability Size / Price Qty
5860-AP-010
Best Seller
R&D Systems Recombinant Proteins and Enzymes
1 Image
Product Details
Citations (11)
FAQs
Reviews (12)

Recombinant Human APRIL/TNFSF13 (HEK293-expressed) Protein Summary

Product Specifications

Purity
>90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
Activity
Measured in a cell proliferation assay using anti-IgM stimulated mouse B cells. The ED50 for this effect is 5-25 ng/mL in the presence of goat anti-mouse IgM.
Source
Human embryonic kidney cell, HEK293-derived human APRIL/TNFSF13 protein
HA
(YPYDVPDYA)
GCN4-IZ GGGSGGGSGGGS Human April
(Ala105-Leu250)
Accession # O75888
N-terminus C-terminus
Accession #
N-terminal Sequence
Analysis
Tyr
Predicted Molecular Mass
21.7 kDa
SDS-PAGE
26 kDa, reducing conditions

Product Datasheets

You must select a language.

x

5860-AP (with carrier)

You must select a language.

x

5860-AP/CF (carrier free)

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

5860-AP

Formulation Lyophilized from a 0.2 μm filtered solution in Tris-HCl and NaCl with BSA as a carrier protein.
Reconstitution Reconstitute at 100 μg/mL in PBS containing at least 0.1% human or bovine serum albumin.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

5860-AP/CF

Formulation Lyophilized from a 0.2 μm filtered solution in Tris-HCl and NaCl.
Reconstitution Reconstitute at 100 μg/mL in PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.
Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: APRIL/TNFSF13

APRIL (a proliferation-inducing ligand), also known as TNFSF13, TALL2, TRDL1, and CD256, is a member of the TNF ligand superfamily (1). It is synthesized as a 32 kDa proprotein which is cleaved by furin in the Golgi to release the active 17 kDa soluble molecule (2-4). Secreted human APRIL, which consists almost entirely of a single TNF homology domain, shares 85% amino acid sequence identity with mouse and rat APRIL (2, 3). Both APRIL and its close relative BAFF bind and signal through the TNF superfamily receptors TACI and BCMA, while BAFF additionally functions through BAFF R (2, 5, 6). APRIL binds to heparan sulfate proteoglycans (HSPGs) independently of its binding to TACI and BCMA (6, 7). The interaction with HSPGs induces APRIL oligomerization, and this augments TACI-, or BMCA-mediated effects (7, 8). HSPGs are also critical for the tumor growth-promoting effects attributed to APRIL (6). APRIL can form bioactive heterotrimers with BAFF, and these circulate in the serum of patients with rheumatic immune disorders (10). TWE-PRIL is a bioactive hybrid protein produced by gene splicing. It consists of the intracellular domain, transmembrane segment, and stalk region of TWEAK fused to the TNF homology domain of APRIL (11). TWE-PRIL is expressed in monocytes and activated T cells and, in contrast to APRIL, is presented on the cell surface (11). APRIL enhances the proliferation and survival of plasma cells and also promotes T cell-dependent humoral responses (2, 12, 13). In the context of autoimmune disorders, however, APRIL can inhibit pathologic humoral responses as well as disease progression (14). Its expression by CD4+ T cells inhibits the production of Th2 cytokines and allergic inflammation (15). APRIL levels are elevated in the serum during coronary artery disease (16), and it is also elevated in many cancers primarily due to expression by tumor-infiltrating neutrophils (4, 7, 17).

References
  1. Planelles, L. et al. (2008) Curr. Mol. Med. 8:829.
  2. Yu, G. et al. (2000) Nat. Immunol. 1:252.
  3. Lopez-Fraga, M. et al. (2001) EMBO Reports 2:945.
  4. Kelly, K. et al. (2000) Cancer Res. 60:1021.
  5. Day, E.S. et al. (2005) Biochemistry 44:1919.
  6. Bossen, C. et al. (2006) J. Biol. Chem. 281:13964.
  7. Hendriks, J. et al. (2005) Cell Death Differ. 12:637.
  8. Schwaller, J. et al. (2007) Blood 109:331.
  9. Ingold, K. et al. (2005) J. Exp. Med. 201:1375.
  10. Roschke, V. et al. (2002) J. Immunol. 169:4314.
  11. Pradet-Balade, B. et al. (2002) EMBO J. 21:5711.
  12. Benson, M.J. et al. (2008) J. Immunol. 180:3655.
  13. He, B. et al. (2004) J. Immunol. 172:3268.
  14. Fernandez, L. et al. (2012) Ann. Rheum. Dis. 72:1367.
  15. Xiao, Y. et al. (2011) Eur. J. Immunol. 41:164.
  16. Sandberg, W.J. et al. (2009) Thromb. Haemost. 102:704.
  17. Mhawech-Fauceglia, P. et al. (2008) Eur. J. Cancer 44:2097.
Long Name
A Proliferation-inducing Ligand
Entrez Gene IDs
8741 (Human); 69583 (Mouse); 287437 (Rat)
Alternate Names
A proliferation-inducing ligand; APRIL; APRILFLJ57090; CD256 antigen; CD256; TALL2; TALL-2; TNF- and APOL-related leukocyte expressed ligand 2; TNF-related death ligand 1; TNFSF13; TRDL1; TRDL-1; tumor necrosis factor (ligand) superfamily, member 13; tumor necrosis factor ligand superfamily member 13; tumor necrosis factor-like protein ZTNF2; tumor necrosis factor-related death ligand-1; ZTNF2

Citations for Recombinant Human APRIL/TNFSF13 (HEK293-expressed) Protein

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

11 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Macrophages drive KSHV B cell latency
    Authors: Szymula, A;Samayoa-Reyes, G;Ogolla, S;Liu, B;Li, S;George, A;Van Sciver, N;Rochford, R;Simas, JP;Kaye, KM;
    Cell reports
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  2. A BAFF/APRIL axis regulates obesogenic diet-driven weight gain
    Authors: CC Chan, ITW Harley, PT Pfluger, A Trompette, TE Stankiewic, JL Allen, ME Moreno-Fer, MSMA Damen, JR Oates, PC Alarcon, JR Doll, MJ Flick, LM Flick, J Sanchez-Gu, R Mukherjee, R Karns, M Helmrath, TH Inge, SP Weisberg, SJ Pamp, DA Relman, RJ Seeley, MH Tschöp, CL Karp, S Divanovic
    Nature Communications, 2021-05-18;12(1):2911.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  3. APRIL and BAFF: novel biomarkers for central nervous system lymphoma
    Authors: M Mulazzani, M Huber, S Borchard, S Langer, B Angele, E Schuh, E Meinl, M Dreyling, T Birnbaum, A Straube, U Koedel, L von Baumga
    J Hematol Oncol, 2019-10-15;12(1):102.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  4. Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica
    Authors: R Wilson, M Makuch, AK Kienzler, J Varley, J Taylor, M Woodhall, J Palace, MI Leite, P Waters, SR Irani
    Brain, 2018-04-01;141(4):1063-1074.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  5. An anti-TL1A antibody for the treatment of asthma and inflammatory bowel disease
    Authors: AW Clarke, L Poulton, D Shim, D Mabon, D Butt, M Pollard, V Pande, J Husten, J Lyons, C Tian, AG Doyle
    MAbs, 2018-03-05;0(0):1-43.
    Species: Human
    Sample Types: Recombinant Protein
    Applications: Surface Plasmon Resonance (SPR
  6. EZH2 inhibition by tazemetostat results in altered dependency on B-cell activation signaling�in DLBCL
    Authors: D Brach, D Johnston-B, A Drew, T Lingaraj, V Motwani, NM Warholic, I Feldman, C Plescia, JJ Smith, RA Copeland, H Keilhack, E Chan-Peneb, SK Knutson, SA Ribich, A Raimondi, MJ Thomenius
    Mol. Cancer Ther., 2017-08-23;0(0):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  7. The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells.
    Authors: Saulep-Easton D, Vincent F, Quah P, Wei A, Ting S, Croce C, Tam C, Mackay F
    Leukemia, 2015-07-03;30(1):163-72.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  8. TACI expression and signaling in chronic lymphocytic leukemia.
    Authors: Mamara, Antigoni, Germenis, Anastasi, Kompoti, Maria, Palassopoulou, Maria, Mandala, Eudokia, Banti, Anastasi, Giannakoulas, Nikolaos, Speletas, Matthaio
    J Immunol Res, 2015-04-09;2015(0):478753.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  9. Diversion of the host humoral response: a novel virulence mechanism of Haemophilus influenzae mediated via outer membrane vesicles.
    Authors: Deknuydt F, Nordstrom T, Riesbeck K
    J Leukoc Biol, 2014-02-18;95(6):983-91.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  10. Selective regulation of axonal growth from developing hippocampal neurons by tumor necrosis factor superfamily member APRIL.
    Authors: Osorio C, Chacon P, White M, Kisiswa L, Wyatt S, Rodriguez-Tebar A, Davies A
    Mol Cell Neurosci, 2014-01-18;59(0):24-36.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  11. CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications.
    Authors: Tai Y, Landesman Y, Acharya C, Calle Y, Zhong M, Cea M, Tannenbaum D, Cagnetta A, Reagan M, Munshi A, Senapedis W, Saint-Martin J, Kashyap T, Shacham S, Kauffman M, Gu Y, Wu L, Ghobrial I, Zhan F, Kung A, Schey S, Richardson P, Munshi N, Anderson K
    Leukemia, 2013-04-16;28(1):155-65.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay

FAQs

  1. What is the meaning of "HA (YPYDVPDYA)" in the Source section of the datasheet?

    • HA (YPYDVPDYA) stands for Hemagglutinin, which consists of amino acids Tyr-Pro-Tyr-Asp-Val-Pro-Asp-Tyr-Ala. It is a popular epitope tag in proteins with mammalian expression systems.

  2. What is the structure of the Recombinant Human APRIL/TNFSF13 Protein (Catalog # 5860-AP)?

    • We expect this Catalog # 5860-AP to be a non-covalently associated homotrimer as provided.

View all Proteins and Enzyme FAQs

Reviews for Recombinant Human APRIL/TNFSF13 (HEK293-expressed) Protein

Average Rating: 5 (Based on 12 Reviews)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Have you used Recombinant Human APRIL/TNFSF13 (HEK293-expressed) Protein?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


Recombinant Human APRIL/TNFSF13 (HEK293-expressed) Protein
By Gerre Lafond on 02/19/2021
Application: Binding assay/Protein-protein interaction

Recombinant Human APRIL/TNFSF13 (HEK293-expressed) Protein
By Anthony Freeman on 12/02/2020
Application: Cell migration/motility

Recombinant Human APRIL/TNFSF13 (HEK293-expressed) Protein
By Anonymous on 10/15/2020
Application: Cell migration/motility

Recombinant Human APRIL/TNFSF13 (HEK293-expressed) Protein
By Jenna Nguyen on 02/08/2019
Application: Stem/Immune cell maintenance or differentiation

Recombinant Human APRIL/TNFSF13 (HEK293-expressed) Protein
By Jenna Nguyen on 01/30/2019
Application: Enzymatic activity in vitro

Recombinant Human APRIL/TNFSF13 (HEK293-expressed) Protein
By Jenna Nguyen on 01/30/2019
Application: Binding assay/Protein-protein interaction

Recombinant Human APRIL/TNFSF13 (HEK293-expressed) Protein
By Laura Howard on 01/16/2019
Application: In vitro bioactivity in cell culture
Reason for Rating: Reliably promotes neurite outgrown of newborn mouse sympathetic neurons of the superior cervical ganglion.

Soluble APRIL enhances NGF-promoted axon growth from SCG neurons. (A) Images of representative calcein-labelled newborn SCG neurons incubated for 16 h in medium containing 0.1 ng/ml NGF and 25 µM Boc-D-FMK with and without 100 ng/ml soluble recombinant APRIL. Scale bar:100 µm. (B) Bar charts of total length of axons in the arbors of P0 SCG neurons grown for 16 h in medium containing 0.1 ng/ml NGF, 25 µM Boc-D-FMK and different concentrations of APRIL.


Recombinant Human APRIL/TNFSF13 (HEK293-expressed) Protein
By Jenna Nguyen on 12/06/2018
Application: Cell Adhesion

Recombinant Human APRIL/TNFSF13 (HEK293-expressed) Protein
By Jenna Nguyen on 12/06/2018
Application: In vitro bioactivity in cell culture

Recombinant Human APRIL/TNFSF13 (HEK293-expressed) Protein
By Jenna Nguyen on 11/05/2018
Application: SDS-PAGE Control

Recombinant Human APRIL/TNFSF13 (HEK293-expressed) Protein
By Jenna Nguyen on 11/05/2018
Application: Binding assay/Protein-protein interaction

Recombinant Human APRIL/TNFSF13 (HEK293-expressed) Protein
By Jenna Nguyen on 07/27/2018
Application: Apoptosis assay